AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8899390 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe obesity (defined using national criteria for severely elevated body mass index)
Number of subjects: 224
Study 8899390 — intervention group
Group type: COMPARATOR
Intervention: Control group (matched controls)
Number of subjects: 224
Study 2626517 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo condition
Number of subjects: 16
Study 2626517 — intervention group
Group type: COMPARATOR
Intervention: Naloxone condition
Number of subjects: 16
Study 795439 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexatopic ointment (17 beta‐hydroxy‐4‐estren‐3‐one‐17‐decanoate)
Number of subjects: 81
Study 795439 — intervention group
Group type: COMPARATOR
Intervention: Reference ointment
Number of subjects: 81
Study 31475597 — intervention group
Group type: EXPERIMENTAL
Intervention: Cut umbilical cord milking (C‐UCM)
Number of subjects: 62
Study 31475597 — intervention group
Group type: COMPARATOR
Intervention: Intact umbilical cord milking (I‐UCM)
Number of subjects: 62
Study 31628586 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine (500-mg tablet, 2-3 times daily)
Number of subjects: 42
Study 31675599 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic orthosis
Number of subjects: 24
Study 31675599 — intervention group
Group type: EXPERIMENTAL
Intervention: Static orthosis
Number of subjects: 24
Study 31675599 — intervention group
Group type: COMPARATOR
Intervention: Both orthoses
Number of subjects: 24
Study 28981445 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey cream
Number of subjects: 120
Study 28981445 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin cream
Number of subjects: 120
Study 28981445 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 120
Study 28981445 — intervention group
Group type: COMPARATOR
Intervention: All groups (Honey, Phenytoin, Placebo)
Number of subjects: 120
Study 25678778 — intervention group
Group type: EXPERIMENTAL
Intervention: FDC of gemigliptin/metformin 25/500 mg
Number of subjects: 28
Study 25678778 — intervention group
Group type: COMPARATOR
Intervention: Separate tablets of gemigliptin (50 mg) and metformin XR (500 mg)
Number of subjects: 28
Study 23470575 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum 4 times a day postoperatively
Number of subjects: 161
Study 23470575 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard postoperative feeding without chewing gum)
Number of subjects: 161
Study 21563551 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactory stimulation with 2-phenyl ethyl alcohol
Number of subjects: 16
Study 21563551 — intervention group
Group type: EXPERIMENTAL
Intervention: Trigeminal stimulation with CO2
Number of subjects: 16
Study 21563551 — intervention group
Group type: COMPARATOR
Intervention: Early blind subjects
Number of subjects: 16
Study 21563551 — intervention group
Group type: COMPARATOR
Intervention: Sighted controls
Number of subjects: 16
Study 20099536 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive behavioral treatment
Number of subjects: 89
Study 20099536 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help program with telephone follow-up
Number of subjects: 89
Study 20099536 — intervention group
Group type: COMPARATOR
Intervention: Brief counseling plus information pamphlet
Number of subjects: 89
Study 16760174 — intervention group
Group type: EXPERIMENTAL
Intervention: Dacarbazine (DTIC) followed by 6‐month treatment with 3 MU thrice weekly of highly purified natural interferon‐alpha (n = 128; arm A)
Number of subjects: 252
Study 16760174 — intervention group
Group type: COMPARATOR
Intervention: No adjuvant treatment (n = 124; arm B)
Number of subjects: 252
Study 15288157 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol CR/XL
Number of subjects: 915
Study 11297592 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg moclobemide for 75 days
Number of subjects: 21
Study 11297592 — intervention group
Group type: COMPARATOR
Intervention: Oral fluocortolone (tapered until day 29)
Number of subjects: 21
Study 11297592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 9709281 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening mammography among women aged 50 to 69 years
Number of subjects: 2
Study 9709281 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening mammography among women aged 40 to 49 years
Number of subjects: 2
Study 8302147 — intervention group
Group type: COMPARATOR
Intervention: 1% epidural lidocaine with 1:200000 epinephrine (Gp.E)
Number of subjects: 60
Study 8302147 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 micrograms/kg alfentanil initially and 7 micrograms/kg on demand intravenously (Gp.A)
Number of subjects: 60
Study 8302147 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 micrograms/kg fentanyl initially and 2 micrograms/kg on demand intravenously (Gp.F)
Number of subjects: 60
Study 2949907 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium replete state
Number of subjects: 8
Study 2949907 — intervention group
Group type: COMPARATOR
Intervention: Sodium deplete state
Number of subjects: 8
Study 31883426 — intervention group
Group type: EXPERIMENTAL
Intervention: Letermovir
Number of subjects: 70
Study 31883426 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 30497798 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg GLA5PR GLARS-NF1 tablet (controlled-release) taken once daily after a high-fat meal (STF treatment)
Number of subjects: 54
Study 30497798 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg GLA5PR GLARS-NF1 tablet (controlled-release) taken in an overnight-fasted state (ST treatment)
Number of subjects: 54
Study 30497798 — intervention group
Group type: COMPARATOR
Intervention: 75 mg IR capsules taken twice daily (MRF treatment)
Number of subjects: 54
Study 27329280 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolmitriptan nasal spray 5 mg
Number of subjects: 798
Study 27329280 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolmitriptan nasal spray (all doses)
Number of subjects: 798
Study 27329280 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 798
Study 25567584 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted implementation strategy including education, audit and feedback, organizational interventions, team-directed interventions, reminders, and patient-mediated interventions.
Number of subjects: 9
Study 25567584 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted implementation strategy
Number of subjects: 9
Study 22337343 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory focusing
Number of subjects: 123
Study 22337343 — intervention group
Group type: EXPERIMENTAL
Intervention: Active distraction
Number of subjects: 123
Study 22337343 — intervention group
Group type: COMPARATOR
Intervention: Undirected control
Number of subjects: 123
Study 22337343 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-colposcopy psychometric measures
Number of subjects: 123
Study 22337343 — intervention group
Group type: EXPERIMENTAL
Intervention: State anxiety post-colposcopy
Number of subjects: 123
Study 19771504 — intervention group
Group type: EXPERIMENTAL
Intervention: EDM feedback counseling
Number of subjects: 80
Study 19771504 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 80
Study 18687830 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound measurements of the median nerve cross-sectional area at the tunnel inlet
Number of subjects: 27
Study 18687830 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound parameters
Number of subjects: 27
Study 15755389 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular (IM) administration of flu vaccine (FV)
Number of subjects: 59
Study 15755389 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous (SC) administration of flu vaccine (FV)
Number of subjects: 59
Study 12438002 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokinesis-block micronucleus (CBMN) assay in peripheral lymphocytes
Number of subjects: 29
Study 12438002 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokinesis-block micronucleus (CBMN) assay with fluorescent in situ hybridization
Number of subjects: 29
Study 12438002 — intervention group
Group type: COMPARATOR
Intervention: Cytokinesis-block micronucleus (CBMN) assay
Number of subjects: 29
Study 10619106 — intervention group
Group type: COMPARATOR
Intervention: Normal volunteers
Number of subjects: 26
Study 10619106 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with cerebral palsy
Number of subjects: 26
Study 7795944 — intervention group
Group type: EXPERIMENTAL
Intervention: Matrix task
Number of subjects: 0
Study 7795944 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal task
Number of subjects: 0
Study 7795944 — intervention group
Group type: EXPERIMENTAL
Intervention: Random generation of numbers (secondary task)
Number of subjects: 0
Study 1851340 — intervention group
Group type: EXPERIMENTAL
Intervention: Zileuton (800 mg, single oral dose)
Number of subjects: 9
Study 6996072 — intervention group
Group type: EXPERIMENTAL
Intervention: Diflunisal (0.5‐1 g/day)
Number of subjects: 0
Study 6996072 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (2‐4 g/day)
Number of subjects: 0
Study 31771599 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent multidisciplinary collaborative intervention
Number of subjects: 503
Study 31771599 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 503
Study 28547861 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual nitroglycerin (0.4 mg)
Number of subjects: 42
Study 28547861 — intervention group
Group type: EXPERIMENTAL
Intervention: Inorganic nitrate (12.9 mmoL)
Number of subjects: 42
Study 26062186 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and moxibustion treatment applied twice a week for 8 weeks.
Number of subjects: 44
Study 26062186 — intervention group
Group type: COMPARATOR
Intervention: Blank control group receiving health and psychological guidance only.
Number of subjects: 44
Study 24053172 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated community case management of malaria and pneumonia
Number of subjects: 1276
Study 20680890 — intervention group
Group type: EXPERIMENTAL
Intervention: Shape combined with size or colour in classification tasks
Number of subjects: 340
Study 20680890 — intervention group
Group type: COMPARATOR
Intervention: Shape irrelevant to the task
Number of subjects: 340
Study 20680890 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple similarity effects in clustering
Number of subjects: 340
Study 19261602 — intervention group
Group type: EXPERIMENTAL
Intervention: Cavotricuspid isthmus block (CTIB) in addition to circumferential pulmonary vein ablation (CPVA)
Number of subjects: 149
Study 19261602 — intervention group
Group type: COMPARATOR
Intervention: Circumferential pulmonary vein ablation (CPVA) alone
Number of subjects: 149
Study 19261602 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall patients after a single procedure
Number of subjects: 149
Study 19261602 — intervention group
Group type: EXPERIMENTAL
Intervention: Including reprocedures
Number of subjects: 149
Study 19261602 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with documented AF or AFL in Holter recordings at 12 months
Number of subjects: 149
Study 17439907 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba (GB), 120 mg twice a day for 12 weeks
Number of subjects: 38
Study 17439907 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 15298718 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 5 x 200 microg (1 orally, 2 sublingually, 2 rectally)
Number of subjects: 237
Study 15298718 — intervention group
Group type: COMPARATOR
Intervention: Placebo (similar to misoprostol)
Number of subjects: 237
Study 15298718 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 237
Study 12428182 — intervention group
Group type: EXPERIMENTAL
Intervention: Eight-polar tactile-electrode impedance method
Number of subjects: 50
Study 9640413 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous GH replacement for 3 years (Group A)
Number of subjects: 15
Study 9640413 — intervention group
Group type: EXPERIMENTAL
Intervention: Short course GH replacement for 6-12 months (Group B)
Number of subjects: 15
Study 7709995 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 400 micrograms
Number of subjects: 190
Study 7709995 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 200 micrograms
Number of subjects: 190
Study 7709995 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study 2766313 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (0.12%) mouthrinse used for 3 weeks
Number of subjects: 10
Study 2766313 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2766313 — intervention group
Group type: COMPARATOR
Intervention: Habitual oral hygiene
Number of subjects: 10
Study 939970 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy totaling 4000 to 4500 rads in 4 to 5 weeks (Group 1)
Number of subjects: 41
Study 939970 — intervention group
Group type: EXPERIMENTAL
Intervention: 1‐(2‐chloroethyl)‐3‐cyclohexyl‐1‐nitrosourea (CCNU) 130 mg/sq m orally every 6 weeks (Group 2)
Number of subjects: 41
Study 939970 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy plus CCNU (Group 3)
Number of subjects: 41
Study 31960448 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU/d vitamin D3
Number of subjects: 360
Study 31960448 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 IU/d vitamin D3
Number of subjects: 360
Study 31960448 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study 31559066 — intervention group
Group type: EXPERIMENTAL
Intervention: Health belief model (HBM) education, n=47
Number of subjects: 99
Study 31559066 — intervention group
Group type: COMPARATOR
Intervention: Conventional method education, n=52
Number of subjects: 99
Study 28257318 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-gripping polyester mesh (Progrip)
Number of subjects: 331
Study 28257318 — intervention group
Group type: COMPARATOR
Intervention: Sutured polyester mesh
Number of subjects: 331
Study 24150125 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional athletes
Number of subjects: 172
Study 24150125 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade/middle school athletes
Number of subjects: 172
Study 24150125 — intervention group
Group type: EXPERIMENTAL
Intervention: Collegiate athletes
Number of subjects: 172
Study 24150125 — intervention group
Group type: COMPARATOR
Intervention: All athletes
Number of subjects: 172
Study 24079855 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 226
Study 24079855 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 226
Study 24079855 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 226
Study 24079855 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 226
Study 21626363 — intervention group
Group type: EXPERIMENTAL
Intervention: CT colonography (CTC)
Number of subjects: 921
Study 21626363 — intervention group
Group type: COMPARATOR
Intervention: Barium enema (BE)
Number of subjects: 921
Study 18277876 — intervention group
Group type: EXPERIMENTAL
Intervention: Diskectomy
Number of subjects: 1191
Study 18277876 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 1191
Study 16133077 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.35% povidone-iodine solution followed by normal saline solution
Number of subjects: 244
Study 16133077 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution
Number of subjects: 244
Study 16133077 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 244
Study 12645704 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 180
Study 12645704 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 180
Study 10784629 — intervention group
Group type: EXPERIMENTAL
Intervention: 1p36 loss of heterozygosity (LOH)
Number of subjects: 238
Study 10784629 — intervention group
Group type: EXPERIMENTAL
Intervention: 1p36 LOH status in single-copy MYCN cases
Number of subjects: 238
Study 10784629 — intervention group
Group type: EXPERIMENTAL
Intervention: 1p36 LOH in low-risk neuroblastoma patients
Number of subjects: 238
Study 10784629 — intervention group
Group type: EXPERIMENTAL
Intervention: 1p36 LOH in multivariate regression model
Number of subjects: 238
Study 8867559 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide plus amiloride (Group I)
Number of subjects: 0
Study 8867559 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide plus captopril (Group II)
Number of subjects: 0
Study 1361775 — intervention group
Group type: EXPERIMENTAL
Intervention: AA (1%) dialysate for 4 weeks
Number of subjects: 16
Study 1361775 — intervention group
Group type: COMPARATOR
Intervention: Dextrose only (usual treatment) for 4 weeks
Number of subjects: 16
Study 6365233 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexabrix 320 (580 mOsm kg‐1)
Number of subjects: 100
Study 6365233 — intervention group
Group type: COMPARATOR
Intervention: Conray 420 (2500 mOsm kg‐1)
Number of subjects: 100
Study 6365233 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexabrix 320
Number of subjects: 100
Study 6365233 — intervention group
Group type: COMPARATOR
Intervention: Conray 420
Number of subjects: 100
Study 30032889 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother's recorded voice (Group M, n=33)
Number of subjects: 66
Study 30032889 — intervention group
Group type: COMPARATOR
Intervention: Stranger's recorded voice (Group S, n=33)
Number of subjects: 66
Study 27356701 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (listening to classical songs through headphones)
Number of subjects: 73
Study 27356701 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 73
Study 25448628 — intervention group
Group type: EXPERIMENTAL
Intervention: QbOpen (clinician has immediate access to a QbTest report)
Number of subjects: 0
Study 25448628 — intervention group
Group type: COMPARATOR
Intervention: QbBlind (report is withheld until the study end)
Number of subjects: 0
Study 25448628 — intervention group
Group type: EXPERIMENTAL
Intervention: QbOpen
Number of subjects: 0
Study 25448628 — intervention group
Group type: COMPARATOR
Intervention: QbBlind
Number of subjects: 0
Study 22883540 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 0
Study 22883540 — intervention group
Group type: COMPARATOR
Intervention: Business as usual (Control)
Number of subjects: 0
Study 20030904 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycaemic index (LGI) foods
Number of subjects: 38
Study 20030904 — intervention group
Group type: COMPARATOR
Intervention: High glycaemic index (HGI) foods
Number of subjects: 38
Study 18544744 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/d
Number of subjects: 10101
Study 18544744 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10101
Study 16003041 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise capacity (W)
Number of subjects: 39
Study 16003041 — intervention group
Group type: EXPERIMENTAL
Intervention: ST depressions during exercise test
Number of subjects: 39
Study 16003041 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular diameter (cm/m)
Number of subjects: 39
Study 16003041 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular volume (mL/m)
Number of subjects: 39
Study 16003041 — intervention group
Group type: EXPERIMENTAL
Intervention: Right ventricular diameter (cm/m)
Number of subjects: 39
Study 16003041 — intervention group
Group type: EXPERIMENTAL
Intervention: Left atrial volume (mL/m)
Number of subjects: 39
Study 16003041 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke volume (mL/m)
Number of subjects: 39
Study 16003041 — intervention group
Group type: COMPARATOR
Intervention: Interventricular septum thickness (mm)
Number of subjects: 39
Study 16003041 — intervention group
Group type: COMPARATOR
Intervention: Posterior wall thickness (mm)
Number of subjects: 39
Study 12794406 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotyping using restriction fragment length polymorphism
Number of subjects: 46
Study 10966086 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based intervention programs targeting dietary behavior and adolescent substance abuse in 11 intervention communities.
Number of subjects: 14
Study 10966086 — intervention group
Group type: COMPARATOR
Intervention: Control communities (matched controls for the intervention communities).
Number of subjects: 14
Study 9207635 — intervention group
Group type: EXPERIMENTAL
Intervention: TIMI IIIB trial
Number of subjects: 1473
Study 9207635 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary angiography
Number of subjects: 1473
Study 9207635 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical management
Number of subjects: 1473
Study 9207635 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac catheterization and percutaneous transluminal coronary angioplasty or coronary artery bypass graft surgery
Number of subjects: 1473
Study 9207635 — intervention group
Group type: EXPERIMENTAL
Intervention: Proportion of unstable angina and non‐Q wave MI
Number of subjects: 1473
Study 8398323 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative adjuvant doxorubicin with marginal surgery and postoperative radiotherapy (51 Gy in 17 fractions)
Number of subjects: 240
Study 8398323 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage treatment after local recurrence
Number of subjects: 240
Study 8398323 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative adjuvant doxorubicin with marginal surgery and postoperative radiotherapy
Number of subjects: 240
Study 3962762 — intervention group
Group type: EXPERIMENTAL
Intervention: 5000 units calcium heparin subcutaneously 8-hourly for two weeks
Number of subjects: 305
Study 3962762 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 305
Study 31613046 — intervention group
Group type: EXPERIMENTAL
Intervention: Preprocedural anticoagulation (63% of patients, primarily intravenous unfractionated heparin)
Number of subjects: 10064
Study 31613046 — intervention group
Group type: EXPERIMENTAL
Intervention: Preprocedural anticoagulation
Number of subjects: 10064
Study 30214185 — intervention group
Group type: EXPERIMENTAL
Intervention: GFF MDI (glycopyrrolate/formoterol fumarate, 18/9.6 μg, twice daily)
Number of subjects: 20